TABLE 3 Median Percentage of CD95 and CD95L Expression (Range)
Primary Cutaneous CD30+ Lymphoproliferative Disorders | Noncutaneous CD30+ ALCL | |
|---|---|---|
Large, atypical cells | ||
CD95 | 94 (35–100) | 100 (94–100)a |
CD95L | 53 (9–89) | 18 (7–100) |
Small lymphocytes | ||
CD95 | 65 (42–88) | 61.5 (15–89) |
CD95L | 13 (4–32) | 3 (1–15)b |
